Thin-layer chromatographic quantification of magnolol and honokiol in dietary supplements and selected biological properties of these preparations
•Quantification of magnolol and honokiol in dietary supplements by affordable TLC-UV.•Bioactivity profiling of dietary supplements by HPTLC-effect directed analysis.•HPTLC-EDA combined with HPTLC-ESI-MS.•Magnolol, honokiol, piperine and daidzein as bioactive constituents.•Stability assessment of the...
Gespeichert in:
Veröffentlicht in: | Journal of Chromatography A 2020-08, Vol.1625, p.461230, Article 461230 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Quantification of magnolol and honokiol in dietary supplements by affordable TLC-UV.•Bioactivity profiling of dietary supplements by HPTLC-effect directed analysis.•HPTLC-EDA combined with HPTLC-ESI-MS.•Magnolol, honokiol, piperine and daidzein as bioactive constituents.•Stability assessment of the analytes by 2D-HPTLC-MS.
Two isomeric biphenyl neolignans, magnolol and honokiol, are considered as constituents responsible for the healing effect of magnolia bark, a traditional Oriental medicine. To survey the increasing number of dietary supplements that contain magnolia bark or its extract, an affordable quantitative thin-layer chromatography (TLC) – densitometry method was developed. The methanol extracts were analyzed on the silica gel plates after manual sample application using n-hexane – ethyl acetate – ethanol (16:3:1, v/v/v) as a mobile phase. For quantitation, the chromatograms were scanned in the absorbance mode at the wavelength λ = 290 nm. The limits of detection and quantitation were 90 and 280 ng/zone for magnolol and 70 and 200 ng/zone for honokiol, respectively. None of the two targeted neolignans were detected in two of the six analyzed supplements. In the other four samples, the measured amounts were between 0.95-114.69 mg g−1 for magnolol and 4.88-84.86 mg g−1 for honokiol. Moreover, separations of these two neolignans on the TLC and high-performance TLC (HPTLC) layers were compared and HPTLC was combined with antioxidant (DPPH) and antibacterial (Bacillus subtilis and Aliivibrio fischeri) assays and mass spectrometry (MS), using the elution-based interface. Both magnolol and honokiol exhibited effects in all bioactivity assays. The HPTLC-MS tests confirmed purity of neolignan zones in the extracts of dietary supplements and supported tentative identification of the alkaloid piperine and the isoflavone daidzein as additional bioactive components of the investigated dietary supplements. Using the same mobile phase in the orthogonal directions 2D-HPTLC-MS experiments proved degradation, i.e., instability of magnolol and honokiol on the silica gel adsorbent. |
---|---|
ISSN: | 0021-9673 |
DOI: | 10.1016/j.chroma.2020.461230 |